Indofarma Tbk (INAF) — Cash Flow Quality Index

Latest as of September 2021: 25.56x

Indofarma Tbk (INAF) has a Cash Flow Quality Index of 25.56x as of September 2021. Operating cash flow of Rp47.20 Billion exceeds net income of Rp1.85 Billion, indicating high earnings quality where cash backs reported profits. Explore INAF cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

25.56x
Operating CF / Net Income

Operating Cash Flow

Rp47.20 Billion
IDR

Net Income

Rp1.85 Billion
IDR

Data as of

Sep 2021
Most recent filing

Indofarma Tbk Cash Flow Quality Index (2000–2020)

Historical Cash Flow Quality Index for Indofarma Tbk across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Indofarma Tbk (INAF) cash conversion ratio.

Annual Cash Flow Quality Index for Indofarma Tbk (2000–2020)

Year-by-year earnings quality comparison for Indofarma Tbk.

Year Quality Index Operating CF (IDR) Net Income YoY Change
2020 1687.69x Rp46.55 Billion Rp27.58 Million ▲ +64522.4%
2019 2.61x Rp20.79 Billion Rp7.96 Billion ▼ -87.2%
2015 20.45x Rp134.28 Billion Rp6.57 Billion ▼ -84.0%
2014 127.55x Rp148.73 Billion Rp1.17 Billion ▲ +13312.9%
2012 -0.97x Rp-40.91 Billion Rp42.38 Billion ▼ -221.2%
2011 0.80x Rp29.40 Billion Rp36.92 Billion ▼ -57.9%
2010 1.89x Rp23.71 Billion Rp12.55 Billion ▼ -90.1%
2009 19.08x Rp40.56 Billion Rp2.13 Billion ▲ +151.3%
2008 -37.22x Rp-187.31 Billion Rp5.03 Billion ▼ -594.3%
2007 7.53x Rp83.42 Billion Rp11.08 Billion ▲ +56.9%
2006 4.80x Rp73.15 Billion Rp15.24 Billion ▲ +183.9%
2005 -5.72x Rp-54.87 Billion Rp9.59 Billion ▼ -126.0%
2004 22.00x Rp159.25 Billion Rp7.24 Billion ▲ +8871.4%
2000 0.25x Rp27.05 Billion Rp110.29 Billion —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.